AminoChain announces Specimen Center launch

Be one of the first invited to test the Platform - sign up for our waitlist today!

Biobanks are the backbone of biomedical research and drug discovery, safeguarding millions of human biospecimens including blood, tissue, DNA, and other biological materials, collected from donors across a variety of healthcare, research, and clinical settings. These invaluable resources fuel breakthroughs in disease research, new treatments, and the advancement of personalized medicine.

Yet despite their critical role, biobanks struggle to operate efficiently in a fragmented ecosystem. Researchers looking for biospecimens face major barriers that slow down scientific progress:

🔍 Limited Sample Visibility & Accessibility

Most biobanks operate in silos, with no centralized system for researchers to search, compare, or request samples across multiple repositories. This lack of visibility leads to duplicated collections, wasted resources, and underutilized specimens, slowing down critical research.

⏳ Cumbersome & Bureaucratic Procurement Processes

The process of acquiring biospecimens is manual, fragmented, and painfully slow. Researchers must contact multiple biobanks, negotiate Material Transfer Agreements (MTAs), verify ethical approvals, and coordinate logistics – a process that often takes 8+ weeks for a single transaction.

🚫 Lack of Transparency & Compliance Oversight

Once a sample is collected, it often disappears into a “black box”, with little traceability on its future use. Donors remain uninformed about how their contributions are used, while institutions struggle to enforce consent terms and regulatory compliance (e.g., GDPR, HIPAA, IRB approvals).

💸 High Costs & Operational Inefficiencies

Without a standardized system for biobanks to connect and share inventories, institutions waste time and money on administrative overhead. Researchers face inflated costs due to middlemen, long processing times, and inefficiencies, further slowing down scientific discovery.

AminoChain’s Solution: The Specimen Center

To address these challenges, AminoChain is launching the Specimen Center, a platform that enables biobanks, clinical sites, and research institutions to seamlessly connect, share, and distribute biosamples across a federated network. By integrating with existing Laboratory Inventory Management Systems (LIMS), the Specimen Center ensures that up-to-date biosample inventories and research data can be easily searched, queried, and requested across multiple organizations.

Key features of the Specimen Center include:

🥼 Full Provider Control

Biobanks remain in full control of their MTAs and sample distribution. They decide which collections to make visible across the network and can restrict access to specific researchers (e.g., academia vs. industry).

🧬 Real-Time Inventory Updates

By integrating with LIMS and data capture software, biobanks can provide real-time insights into available samples and data. These integrations can be configured as read-only, ensuring providers maintain full control over their data.

📊 Advanced Search & AI-Driven Analytics

The Specimen Center features machine learning-powered search and semantic analytics, allowing researchers to quickly find the most relevant biospecimens and data based on complex queries and research needs.

🧪 Faster, Direct Procurement Without Middlemen

By making biosample inventories visible to a growing network of research institutions, biotech companies, and CROs, biobanks can increase direct sample exchanges. As a peer-to-peer distribution platform, the Specimen Center eliminates unnecessary intermediaries, reducing transaction delays and costs.

📢 Announcing the General Availability of the Specimen Center – May 14, 2025

We are thrilled to announce that on May 14, 2025, the Specimen Center, AminoChain’s flagship application, will be available for general use.

This launch represents a new era in biomedical research, where biospecimens are easier to find, access, and utilize than ever before. Whether you’re a researcher in need of high-quality biospecimens or a biobank looking to increase visibility and utilization, AminoChain provides the trusted infrastructure to make biospecimen procurement faster, more ethical, and highly efficient.

📅 Mark your calendar for May 14th and be among the first to experience the future of decentralized biobanking.